The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Gene Review

SSTR  -  hypothetical gene supported by NM_133522

Rattus norvegicus

This record was replaced with 171044.
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of SSTR

  • It is hypothesized that the effect of neuropeptide somatostatin (SS-14) on murine colonic cancer is exerted via the subtype of receptor which does not interact with CH-275 and has no or low affinity for octreotide (SSTR 4, 3 or 5?) [1].
  • The purpose of this study was to define the presence and abundance of SSTR subtypes in a rat iliac balloon injury model of intimal hyperplasia [2].
 

High impact information on SSTR

  • METHODS: SSTR messenger RNA expression, and SSTR presence was investigated using reverse-transcription polymerase chain reaction, real-time quantitative polymerase chain reaction, Western blotting, and immunohistochemistry [3].
  • The aims of this study were to investigate expression of somatostatin receptor subtypes (SSTRs) 1-5 in rat colonic epithelium and to identify which subtype(s) mediate inhibition of adenosine 3', 5'-cyclic monophosphate (cAMP)-activated secretion using SSTR-selective analogues [4].
  • These data indicate that the hippocampal functions of somatostatin might be mediated through diverse but selective second messenger systems activated via SSTR4 and reveal an unsuspected coupling of a neuronal SSTR subtype to a mitogenic signaling pathway [5].
  • In vivo behavioral studies demonstrate that intraplantar injection of 20.0 but not 2.0 microM octreotide (OCT, SSTR agonist) significantly reduces capsaicin (CAP, a ligand for TRPV1) -induced flinching and lifting/licking behaviors [6].
  • Furthermore, blockade of peripheral SSTRs with c-SOM dramatically enhances CAP-induced behaviors and nociceptor activity, demonstrating SSTR-induced tonic inhibitory modulation of TRPV1 [6].
 

Biological context of SSTR

 

Anatomical context of SSTR

  • Therefore, we examined the expression of mRNA for the five recently cloned SSTR subtypes in the pituitary and hypothalamus of FD and STZ diabetic rats [10].
  • The pituitary plasma membrane SSTR concentration was reduced over 50% in FD vs. fed animals [10].
  • We investigated the possibility that the SST receptor (SSTR) is expressed in skeletal muscle [8].
  • Recently, SS and its receptor (SSTR) have been demonstrated in lymphoid tissues and seem to play a regulatory, largely inhibitory, role in immune responses [11].
  • Calculated tumor, kidney and bone marrow doses for 66Ga-DOTATOC based on biodistribution data were 178, 109 and 1.2 cGy/MBq, respectively.We conclude that 66Ga labeled DOTATOC can be used for PET diagnosis and quantitative imaging-based dosimetry of SSTR positive tumors [12].
 

Associations of SSTR with chemical compounds

  • SSTR antigens were colocalized in GH positive cells using rhodamine conjugated secondary antibody for SSTRs and FITC-conjugated secondary antibody for GH [13].
  • When AR42J cells were exposed to the cholinergic agonist carbachol in the presence of somatostatin or selective SSTR agonists, significant and dose-dependent reductions in agonist-induced levels of mRNA were noted [9].
 

Regulatory relationships of SSTR

 

Analytical, diagnostic and therapeutic context of SSTR

  • The presence of SSTR subtypes 1, 2, and 3 was confirmed by Western blotting [3].
  • With immunohistochemistry, a strong staining of HSCs was obtained for SSTR subtypes 1, 2, and 3 in CCl4-treated rats, but not in normal rat liver [3].
  • CONCLUSION: The high SSTR-binding affinity and high receptor-specific and saturable in vivo tumor uptake indicate that 99mTc-P587 and 99mTc-P829 are promising radiotracers for the clinical detection of SSTR-expressing tumors and other tissues by 99mTc gamma scintigraphy [15].
  • By RT-PCR, it was found that AR42J expresses all of the five subtypes of the somatostatin (SST) receptor (SSTR) family, except SSTR4 [16].

References

  1. Effects of somatostatin and its analogues on tyrosine kinase activity in rodent tumors. Lachowicz-Ochedalska, A., Rebas, E., Kunert-Radek, J., Winczyk, K., Pawlikowski, M. Biological signals and receptors. (2000) [Pubmed]
  2. Somatostatin receptor expression in rat iliac arteries after balloon injury. Chen, J.C., Hsiang, Y.N., Buchan, A.M. Journal of investigative surgery : the official journal of the Academy of Surgical Research. (1997) [Pubmed]
  3. Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1. Reynaert, H., Vaeyens, F., Qin, H., Hellemans, K., Chatterjee, N., Winand, D., Quartier, E., Schuit, F., Urbain, D., Kumar, U., Patel, Y.C., Geerts, A. Gastroenterology (2001) [Pubmed]
  4. Somatostatin receptor subtype 2 mediates somatostatin inhibition of ion secretion in rat distal colon. Warhurst, G., Higgs, N.B., Fakhoury, H., Warhurst, A.C., Garde, J., Coy, D.H. Gastroenterology (1996) [Pubmed]
  5. Functional coupling of SSTR4, a major hippocampal somatostatin receptor, to adenylate cyclase inhibition, arachidonate release and activation of the mitogen-activated protein kinase cascade. Bito, H., Mori, M., Sakanaka, C., Takano, T., Honda, Z., Gotoh, Y., Nishida, E., Shimizu, T. J. Biol. Chem. (1994) [Pubmed]
  6. Somatostatin modulates the transient receptor potential vanilloid 1 (TRPV1) ion channel. Carlton, S.M., Zhou, S., Du, J., Hargett, G.L., Ji, G., Coggeshall, R.E. Pain (2004) [Pubmed]
  7. Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Bruno, J.F., Xu, Y., Song, J., Berelowitz, M. Endocrinology (1993) [Pubmed]
  8. Expression of somatostatin receptor genes and acetylcholine receptor development in rat skeletal muscle during postnatal development. Peng, M., Conforti, L., Millhorn, D.E. Int. J. Mol. Med. (1998) [Pubmed]
  9. Regulation of carbachol-induced c-fos mRNA expression in AR42J cells by somatostatin receptor subtypes 1, 2, and 3. Cowles, R.A., Segura, B.J., Mulholland, M.W. Pancreas (2002) [Pubmed]
  10. Pituitary and hypothalamic somatostatin receptor subtype messenger ribonucleic acid expression in the food-deprived and diabetic rat. Bruno, J.F., Xu, Y., Song, J., Berelowitz, M. Endocrinology (1994) [Pubmed]
  11. Evidence that SMS 201-995 enhances the immunosuppressive effect of FK506. Perego, C., Lattuada, D., Casnici, C., Gatti, S., Orsenigo, R., Panagiotis, S., Franco, P., Marelli, O. Int. J. Immunopharmacol. (1998) [Pubmed]
  12. Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors. Ugur, O., Kothari, P.J., Finn, R.D., Zanzonico, P., Ruan, S., Guenther, I., Maecke, H.R., Larson, S.M. Nucl. Med. Biol. (2002) [Pubmed]
  13. Expression of the five somatostatin receptor (SSTR1-5) subtypes in rat pituitary somatotrophes: quantitative analysis by double-layer immunofluorescence confocal microscopy. Kumar, U., Laird, D., Srikant, C.B., Escher, E., Patel, Y.C. Endocrinology (1997) [Pubmed]
  14. Anti-secretory properties of non-peptide somatostatin receptor agonists in isolated rat colon: luminal activity and possible interaction with P-glycoprotein. Emery, P.T., Higgs, N.B., Warhurst, A.C., Carlson, G.L., Warhurst, G. Br. J. Pharmacol. (2002) [Pubmed]
  15. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides. Vallabhajosula, S., Moyer, B.R., Lister-James, J., McBride, B.J., Lipszyc, H., Lee, H., Bastidas, D., Dean, R.T. J. Nucl. Med. (1996) [Pubmed]
  16. Expression of chromogranin A and somatostatin receptors in pancreatic AR42J cells. Hofsli, E., Thommesen, L., Nørsett, K., Falkmer, S., Syversen, U., Sandvik, A., Laegreid, A. Mol. Cell. Endocrinol. (2002) [Pubmed]
 
WikiGenes - Universities